SY
Healthcare & Life Sciences
Symphogen
Denmark
Symphogen is a Healthcare & Life Sciences startup based in Denmark, most recent round Series C+, 3 tracked investors.
series-c-plus
series-c-plus
Stage
3
Investors
About Symphogen
Symphogen is a startup based in Denmark. Its most recent tracked round is Series C+. Brouky classifies it under Healthcare & Life Sciences. Brouky records 3 investors associated with the company.
Symphogen develops antibody-based therapies using proprietary antibody mixture technology aimed at treating cancer and other diseases by creating synergistic therapeutic effects.
Explore Symphogen's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.